In the year 2013, Mirna Therapeutics announced to the world that Clay Siegel would be the newly appointed Board of Directors. Clay Siegall was formerly the Chairman Board of Directors and Chief Executive Director of the company Seattle Genetics. Clay Siegall was the founder of Seattle Genetics where he created a successful anti – body treatment for patients with cancer. Siegall is highly educated in the field. He has published over 70 works as well as holding 15 patents.
Clay Siegall is the CEO of Seattle Genetics which is a company that is concentrated on finding breakthroughs within the anti-body based therapies that are used when treating cancer. Seattle Genetics is the top leader in creating anti-body drug conjugates,otherwise known as ADCs. ADCs are so important to the research of the company because they are used to reduce the harm that can be done by traditional chemotherapy. The company is working day in and day out to create better systems for health needs that are not being met by patients.
The company is built on a set of concrete values that continue the positive growth of the company. Some of these values include a passion for the improvement of patients, integrity when dealing with patients, scientific excellence, and and innovative approach to creating new treatement.
Clay Siegall has been trained in the field of science, while focusing on different types of cancer therapies. Siegall created Seattle Genetics with the hope that the company would find more innovative, and effective, methods when treating patients with cancer. The company has done this under the leadership of Siegall by doing large amounts of research, as well as practices that look out for the well being of every patient. Because of his development of quality products, the company has produced treatments that are able to be sold in over 60 countries. He has entered into different licenses that have made over 325 million dollars.